Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric Asthma Controller Trial (PACT)
NCT00272506Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Aug 2002
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate nasal spray, salmeterol and montelukast in asthma (3 arms), sponsored by National Heart, Lung, and Blood Institute. Primary endpoint: Percentage of Asthma Control Days at 12 months. Started Aug 2002; status: completed.
02
Drugs
fluticasone propionate nasal spraysalmeterolmontelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00272506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00272506.